{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T01:46:10Z","timestamp":1788918370354,"version":"build-2803163510"},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T00:00:00Z","timestamp":1772409600000},"content-version":"vor","delay-in-days":40,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100031514","name":"Chengdu Municipal Health Commission","doi-asserted-by":"crossref","award":["2023001"],"award-info":[{"award-number":["2023001"]}],"id":[{"id":"10.13039\/100031514","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"DOI":"10.1186\/s12887-026-06511-4","type":"journal-article","created":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T08:53:54Z","timestamp":1768985634000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Combination of aztreonam, colistin and tigecycline in the treatment of neonatal carbapenemase-producing Enterobacteriaceae infection: a case report"],"prefix":"10.1186","volume":"26","author":[{"given":"Han","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-1324-8965","authenticated-orcid":false,"given":"Yangyang","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,21]]},"reference":[{"key":"6511_CR1","unstructured":"Wang H, Naghavi M, Allen C, Barber RM, Murray CJL. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015 - Supplementary Information 1. 2016."},{"issue":"2","key":"6511_CR2","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/S2352-4642(21)00311-4","volume":"6","author":"J Perin","year":"2022","unstructured":"Perin J, Mulick A, Yeung D, Villavicencio F, Lopez G, Strong KL, et al. Global, regional, and national causes of under-5 mortality in 2000\u201319: an updated systematic analysis with implications for the sustainable development goals. Lancet Child Adolesc Health. 2022;6(2):106\u201315.","journal-title":"Lancet Child Adolesc Health"},{"key":"6511_CR3","doi-asserted-by":"publisher","unstructured":"Thomas AH, Richard AP. Pneumonia. Semin Fetal Neonatal Med. 2017;22(4). https:\/\/doi.org\/10.1016\/j.siny.2017.03.002.","DOI":"10.1016\/j.siny.2017.03.002"},{"issue":"5","key":"6511_CR4","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1007\/s15010-007-6356-9","volume":"35","author":"Y Huang","year":"2007","unstructured":"Huang Y, Zhuang S, Du M. Risk factors of nosocomial infection with extended-spectrum beta-lactamase-producing bacteria in a neonatal intensive care unit in China. Infection. 2007;35(5):339\u201345.","journal-title":"Infection"},{"key":"6511_CR5","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jgar.2024.02.004","volume":"37","author":"P Fang","year":"2024","unstructured":"Fang P, Gao K, Yang J, Li T, Sun Q, Shan Z, et al. Clinical characteristics and risk factors for neonatal bloodstream infection due to carbapenem-resistant Enterobacteriaceae: a single-centre Chinese retrospective study. J Glob Antimicrob Resist. 2024;37:28\u201336.","journal-title":"J Glob Antimicrob Resist"},{"key":"6511_CR6","doi-asserted-by":"publisher","unstructured":"Jeong YS, Park S, Yon D, Lee S, Tizaoui K, Koyanagi A, Jacob L, Kostev K, Dragioti E, Radu\u00e0 J. Global burden of gout in 1990\u20132019: A systematic analysis of the Global Burden of Disease study 2019. Eur J Clin Investigation. 2022;53. https:\/\/doi.org\/10.1111\/eci.13937.","DOI":"10.1111\/eci.13937"},{"key":"6511_CR7","doi-asserted-by":"publisher","unstructured":"Sands K, Spiller OB, Thomson K, Portal EAR, Iregbu KC, Walsh TR. Early-onset neonatal sepsis in low- and middle-income countries: current challenges and future opportunities. Infect Drug Resist. 2022. https:\/\/doi.org\/10.2147\/idr.s294156.","DOI":"10.2147\/idr.s294156"},{"key":"6511_CR8","unstructured":"Yu Hua XX, Li Min, et al. Expert consensus on laboratory detection and clinical reporting of carbapenem from Enterobacteriaceae (second edition). Chin J Infect Chem. 2022(04):463-474. https:\/\/link.oversea.cnki.net\/doi\/10.16718\/j.1009-7708.2022.04.014."},{"issue":"6","key":"6511_CR9","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.ijantimicag.2015.09.011","volume":"46","author":"D Liu","year":"2015","unstructured":"Liu D, Zhang J, Liu H-X, Zhu Y-G, Qu J-M. Intravenous combined with aerosolised polymyxin versus intravenous polymyxin alone in the treatment of pneumonia caused by multidrug-resistant pathogens: a systematic review and meta-analysis. Int J Antimicrob Agents. 2015;46(6):603\u20139.","journal-title":"Int J Antimicrob Agents"},{"issue":"11","key":"6511_CR10","doi-asserted-by":"publisher","first-page":"e3126","DOI":"10.1097\/MD.0000000000003126","volume":"95","author":"W Ni","year":"2016","unstructured":"Ni W, Han Y, Liu J, Wei C, Zhao J, Cui J, et al. Tigecycline treatment for carbapenem-resistant Enterobacteriaceae infections: a systematic review and meta-analysis. Medicine (Baltimore). 2016;95(11):e3126.","journal-title":"Medicine (Baltimore)"},{"issue":"11","key":"6511_CR11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1097\/INF.0000000000002448","volume":"38","author":"N Nakwan","year":"2019","unstructured":"Nakwan N, Chokephaibulkit K, Imberti R. The use of colistin for the treatment of multidrug-resistant Gram-negative infections in neonates and infants: a review of the literature. Pediatr Infect Dis J. 2019;38(11):1107\u201312.","journal-title":"Pediatr Infect Dis J"},{"key":"6511_CR12","unstructured":"Smith HZ, Hollingshead CM, Kendall B. Carbapenem-Resistant Enterobacterales. StatPearls. 2024. https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK551704\/."},{"issue":"1","key":"6511_CR13","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s12941-019-0334-9","volume":"18","author":"Y Ding","year":"2019","unstructured":"Ding Y, Wang Y, Hsia Y, Sharland M, Heath PT. Systematic review of carbapenem-resistant Enterobacteriaceae causing neonatal sepsis in China. Ann Clin Microbiol Antimicrob. 2019;18(1):36.","journal-title":"Ann Clin Microbiol Antimicrob"},{"issue":"2","key":"6511_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1093\/cid\/ciac268","volume":"75","author":"PD Tamma","year":"2022","unstructured":"Tamma PD, Aitken SL, Bonomo RA, Mathers AJ, van Duin D, Clancy CJ. Infectious Diseases Society of America 2022 Guidance on the Treatment of Extended-Spectrum \u03b2-lactamase Producing Enterobacterales (ESBL-E), Carbapenem-Resistant Enterobacterales (CRE), and Pseudomonas aeruginosa with Difficult-to-Treat Resistance (DTR-P. aeruginosa). Clin Infect Dis. 2022;75(2):187\u2013212.","journal-title":"Clin Infect Dis"},{"issue":"4","key":"6511_CR15","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1080\/14787210.2024.2307912","volume":"22","author":"N Gupta","year":"2024","unstructured":"Gupta N, Boodman C, Prayag P, Manesh A, Kumar TP. Ceftazidime-avibactam and aztreonam combination for carbapenem-resistant Enterobacterales bloodstream infections with presumed Metallo-\u03b2-lactamase production: a systematic review and meta-analysis. Expert Rev Anti-infect Ther. 2024;22(4):203\u20139.","journal-title":"Expert Rev Anti-infect Ther"},{"key":"6511_CR16","doi-asserted-by":"publisher","unstructured":"Mei Z, Jun X, Zhiyong Z, Yi S, Yuxing N, Fupin H, Yijian C, Chao Z, Bijie H, Xiaoju L et al. Guidelines for the diagnosis, treatment, prevention and control of infections caused by carbapenem-resistant gram-negative bacilli. J Microbiol Immunol Infect. 2023;56. https:\/\/doi.org\/10.1016\/j.jmii.2023.01.017.","DOI":"10.1016\/j.jmii.2023.01.017"},{"key":"6511_CR17","doi-asserted-by":"publisher","unstructured":"Tamma PD, Heil EL, Justo JA, Mathers AJ, Satlin MJ, Bonomo RA. Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections. Clin Infect Dis. 2024. https:\/\/doi.org\/10.1093\/cid\/ciae403.","DOI":"10.1093\/cid\/ciae403"},{"key":"6511_CR18","doi-asserted-by":"publisher","unstructured":"Iosifidis E, Chorafa E, Agakidou E, Kontou A, Violaki A, Volakli E, Christou EI, Zarras C, Drossou-Agakidou V, Sdougka M. Use of Ceftazidime-avibactam for the Treatment of Extensively drug-resistant or Pan drug-resistant Klebsiella pneumoniae in Neonates and Children <5 Years of Age. Pediatric Infectious Dis J. 2019;38. https:\/\/doi.org\/10.1097\/inf.0000000000002344.","DOI":"10.1097\/inf.0000000000002344"},{"key":"6511_CR19","first-page":"1","volume":"1","author":"K Kirati","year":"2017","unstructured":"Kirati K, Khachen K, Surasak S, Anucha A, Nathorn C. Comparative efficacy and safety of treatment options for MDR and XDR Acinetobacter baumannii infections: a systematic review and network meta-analysis. J Antimicrob Chemother. 2017;1:1.","journal-title":"J Antimicrob Chemother"},{"key":"6511_CR20","doi-asserted-by":"publisher","unstructured":"Zhu Y, Monsel A, Roberts JA, Pontikis K, Mimoz O, Rello J, Qu J, Rouby JJ. Nebulized Colistin in Ventilator-Associated Pneumonia and Tracheobronchitis: Historical Background, Pharmacokinetics and Perspectives. Microorganisms. 2021;9(6). https:\/\/doi.org\/10.3390\/microorganisms9061154.","DOI":"10.3390\/microorganisms9061154"},{"issue":"31","key":"6511_CR21","doi-asserted-by":"publisher","first-page":"11466","DOI":"10.12998\/wjcc.v10.i31.11466","volume":"10","author":"JL Wang","year":"2022","unstructured":"Wang JL, Xiang BX, Song XL, Que RM, Zuo XC, Xie YL. Prevalence of polymyxin-induced nephrotoxicity and its predictors in critically ill adult patients: a meta-analysis. World J Clin Cases. 2022;10(31):11466\u201385.","journal-title":"World J Clin Cases"},{"issue":"1","key":"6511_CR22","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1002\/ppul.21324","volume":"46","author":"N Nakwan","year":"2011","unstructured":"Nakwan N, Wannaro J, Thongmak T, Pornladnum P, Saksawad R, Nakwan N, et al. Safety in treatment of ventilator-associated pneumonia due to extensive drug-resistant Acinetobacter baumannii with aerosolized colistin in neonates: a preliminary report. Pediatr Pulmonol. 2011;46(1):60\u20136.","journal-title":"Pediatr Pulmonol"},{"issue":"4","key":"6511_CR23","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1002\/ppul.22750","volume":"49","author":"CH Kang","year":"2014","unstructured":"Kang CH, Tsai CM, Wu TH, Wu HY, Chung MY, Chen CC, et al. Colistin inhalation monotherapy for ventilator-associated pneumonia of Acinetobacter baumannii in prematurity. Pediatr Pulmonol. 2014;49(4):381\u20138.","journal-title":"Pediatr Pulmonol"},{"issue":"8","key":"6511_CR24","first-page":"1157","volume":"67","author":"S Choudhry","year":"2017","unstructured":"Choudhry S, Ahmad E, Batool A, Raja N. Use of colistin for the treatment of multi drug resistant isolates in neonates. J Pak Med Assoc. 2017;67(8):1157\u201360.","journal-title":"J Pak Med Assoc"},{"key":"6511_CR25","doi-asserted-by":"publisher","unstructured":"Hussain K, Salat MS, Ambreen G, Mughal A, Idrees S, Sohail M, Iqbal J. Intravenous vs intravenous plus aerosolized colistin for treatment of ventilator-associated pneumonia \u2013 a matched case\u2013control study in neonates. https:\/\/doi.org\/10.1080\/14740338.2020.1819980.","DOI":"10.1080\/14740338.2020.1819980"},{"key":"6511_CR26","doi-asserted-by":"crossref","unstructured":"Tygacil: FDA prescribing information, side effects and uses [EB\/OL]. (2021-06-01) [2024-01-08]. https:\/\/www.drugs.com\/pro\/tygacil.html#moreResources.","DOI":"10.52314\/tjima.2021.v1i1.3"},{"issue":"supp-S4","key":"6511_CR27","doi-asserted-by":"publisher","first-page":"S215","DOI":"10.1016\/S0924-8579(09)70005-6","volume":"32","author":"LR Peterson","year":"2008","unstructured":"Peterson LR. A review of tigecycline\u2013the first glycylcycline. Int J Antimicrob Agents. 2008;32(supp-S4):S215\u201322.","journal-title":"Int J Antimicrob Agents"},{"key":"6511_CR28","doi-asserted-by":"publisher","unstructured":"Shupeng, Lin, Chenmei, Zhang, Sheng, Ye. Preliminary experience of tigecycline treatment for infection in children with hematologic malignancies. Int J Clin Pharmacy. 2018. https:\/\/doi.org\/10.1007\/s11096-018-0690-0.","DOI":"10.1007\/s11096-018-0690-0"},{"issue":"9","key":"6511_CR29","doi-asserted-by":"publisher","first-page":"e0085421","DOI":"10.1128\/AAC.00854-21","volume":"65","author":"Z Zhu","year":"2021","unstructured":"Zhu Z, Yu Q, Qi G, Yang J, Ni Y, Ruan W, et al. Tigecycline-induced tooth discoloration in children younger than eight years. Antimicrob Agents Chemother. 2021;65(9):e0085421.","journal-title":"Antimicrob Agents Chemother"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-026-06511-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-026-06511-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T09:18:21Z","timestamp":1772443101000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-026-06511-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,21]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6511"],"URL":"https:\/\/doi.org\/10.1186\/s12887-026-06511-4","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,21]]},"assertion":[{"value":"28 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This retrospective case report was approved by the Ethics Committee of the Chengdu Women's and Children's Central Hospital, with the approval number: Scientific Research Ethics Approval 2022 (No. 65).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient\u2019s parents for publication of this case report.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"171"}}